Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-767-7 | CAS number: 2893-78-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- August 9 1984 - August 23 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study performed to GLP and guideline. The chlorinated isocyanurates (sodium dichloroisocyanurate and sodium dichloroisocynaurate dihydrate) produce free available chlorine, in the form of hypochlorous acid (HOCl) as they dissolve in water. As the equilibria involve all of the possible chlorinated isocyanurates, the toxicity of sodium dichloroisocyanurate (NaDCC) and sodium dichloroisocyanurate dihydrate (NaDCC.2H2O) will be virtually equivalent at the same available chlorine concentration. The parent compound for all chlorinated isocyanurates is isocyanuric acid (cyanuric acid). All of the chlorinated isocyanurates are essentially equivalent, once they are dissolved in water at the low concentrations at which they are used. Therefore read across from sodium dichloroisocyanurate dihydrate to troclosene sodium is justified.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- GLP compliance:
- yes
Test material
- Reference substance name:
- Sodium dichloroisocyanurate dihydrate
- IUPAC Name:
- Sodium dichloroisocyanurate dihydrate
- Reference substance name:
- 1,3-dichloro-1,3,5-triazine-2,4,6(1H,3H,5H)-trione sodium salt dihydrate
- Cas Number:
- 51580-86-0
- Molecular formula:
- C3Cl2N3O3.2H2O.Na
- IUPAC Name:
- 1,3-dichloro-1,3,5-triazine-2,4,6(1H,3H,5H)-trione sodium salt dihydrate
- Details on test material:
- - Name of test material (as cited in study report): Dichloroisocyanuric acid, sodium salt, dihydrate
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Kingston, New York, USA
- Weight at study initiation: 200.4 – 234.7 g
- Housing: Suspended wire mesh cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: No less than 7 days
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 150, 200, 250, 300 and 400 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg
DOSAGE PREPARATION: The test material was first put through a 40 mesh sieve and then the appropriate amount of test material was weighed on an electronic balance and transferred to a beaker. A small amount of corn oil was first added to make a paste and then the remaining required amount of vehicle was added to the beaker and stirred on a magentic stirrer for approcimately 5 to 10 minutes.
- Doses:
- Range finding study: 500, 1000, 1250, 1500 and 2000 mg/kg bw
Main study: 1500, 2000, 2500, 3000 and 4000 mg/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: All of the rats were observed for signs of toxicity and pharmacologic effects at 1, 2 and 3 hours post does, and once daily thereafter for 14 consecutive days. .
- Frequency of observations and weighing: Mortality and moribundity was recorded twice daily. Individual body weights were recorded prior to treatment, on day 7 and at death or termination
- Necropsy of survivors performed: yes - Statistics:
- The mortality data were anlayzed for the males and the sexes by a logit regression method (Bliss, 1952) and for the females by a modified Behrens-Reed-Muench Method (Thakur and Fezio, 1981).
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 094 mg/kg bw
- 95% CL:
- 1 551 - 2 636
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 671 mg/kg bw
- 95% CL:
- 1 423 - 1 962
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 823 mg/kg bw
- 95% CL:
- 1 479 - 2 166
- Mortality:
- Cumulative mortality data for the range finding study are presented in table 1. The group 5 animal was found dead on day 3 post dose. No mortality occurred in the groups 1-4 animals. Cumulative mortality data for the main study are presented in table 2.
- Clinical signs:
- other: A variety of commonly noted clinical signs were observed in all groups with severity increasing with increasing dose.
- Gross pathology:
- Animals which survived to termination showed no observable gross pathology findings. Gross pathology findings in found dead animals included observations in the stomach, intestines, lung, liver and abdominal cavity
Any other information on results incl. tables
Table 1: Cumulative mortality (range finder)
Group |
Dose level (mg/kg) |
Hours |
Days |
|||||
1 |
2 |
4 |
1 |
2 |
3 |
4 |
||
1 |
500 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1000 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
1250 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
1500 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
2000 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Table 2: Cumulative mortality data (main study)
Group |
Dose level (mg/kg) |
Hours post dose |
Day post dose |
|||||||||||||||
1 |
2 |
4 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
||
|
|
|
|
|
Males |
|||||||||||||
1 |
1500 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2000 |
0 |
0 |
0 |
2 |
2 |
2 |
3 |
3 |
3 |
3 |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
3 |
2500 |
0 |
0 |
0 |
1 |
2 |
2 |
2 |
2 |
2 |
3 |
3 |
4 |
4 |
4 |
4 |
4 |
4 |
4 |
3000 |
0 |
0 |
0 |
1 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
5 |
4000 |
0 |
0 |
0 |
2 |
4 |
4 |
4 |
4 |
4 |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
|
|
|
|
|
Females |
|
||||||||||||
1 |
1500 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
2000 |
0 |
0 |
0 |
3 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
3 |
2500 |
0 |
0 |
0 |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
4 |
3000 |
0 |
0 |
0 |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
4000 |
0 |
0 |
0 |
3 |
4 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
The study was performed on sodium dichloroisocyanurate dihydrate. In order to convert the LD50 values to the anhydrous form the following calculation is applied:
Lowest LD50 = 1671 mg/kg (females)
MW of sodium dichloroisocyanurate dihydrate = 256
MW of sodium dichloroisocyanurate anhydrous = 220
220/256 x 1671 = 1436 mg/kg
Therefore the LD50 value for sodium dichloroisocyanurate anhydrous is 1436 mg/kg
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Sodium dichloroisocyanurate dihydrate is harmful by the oral route based on the LD50 value of 1671 mg/kg bw.
Sodium dichloroisocyanurate anydrous is harmful by the oral route based on the calculated LD50 value of 1436 mg/kg bw
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
